Drexler Pharmaceuticals Private Limited
About Drexler Pharmaceuticals Private Limited
Data last updated:
Drexler Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2015PTC278617. Its GSTIN is 07AAFCD2972C1ZV (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neeraj Gupta and Milky Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. 246 Pocket – 4 Sector – 24 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2021, the company reported a revenue of ₹4.44 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹34,173 (net margin 0.1%) and EBITDA of ₹44,214 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years and 75% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Drexler Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 246 Pocket – 4 Sector – 24 Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Drexler Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Drexler Pharmaceuticals Private Limited
FY 2024 filings availableDrexler Pharmaceuticals Private Limited reported revenue of ₹4.44 Cr (up 17% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 75% over five years, including 17% growth in the latest year. EBITDA rose 169% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹4.44 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44,214 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,173 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Drexler Pharmaceuticals Private Limited, buy the company report.
Board of directors of Drexler Pharmaceuticals Private Limited
Drexler Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Gupta | Director | 31 Mar 2015 | 11 Years 6 Months | Current |
| Milky Gupta | Director | 22 Feb 2016 | 10 Years 8 Months | Current |
Auditor
Drexler Pharmaceuticals Private Limited is audited by NEHRU & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NEHRU & ASSOCIATES | FY 2021 | 029100N |
Shareholding
The shareholding of Drexler Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Drexler Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Drexler Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Drexler Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Drexler Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD2972C1ZV | Delhi | Active | 23 Jan 2018 |
To see the full GST registrations and return filing status of Drexler Pharmaceuticals Private Limited, buy the company report.
Recent activity
Drexler Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Milky Gupta ceased to be Additional Director on 30 Sep 2016.
Frequently asked questions
Drexler Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 March 2015 (11+ years old) and is registered under CIN U24232DL2015PTC278617.
Drexler Pharmaceuticals has 2 current directors:
- Neeraj Gupta - Director
- Milky Gupta - Director
The latest financial statements of Drexler Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Drexler Pharmaceuticals is 07AAFCD2972C1ZV, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Drexler Pharmaceuticals is U24232DL2015PTC278617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Drexler Pharmaceuticals was incorporated on 31 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Milky Gupta ceased to be Additional Director on 30 Sep 2016. Milky Gupta was appointed as Director on 22 Feb 2016. Sachin Jain ceased to be Additional Director on 22 Feb 2016. Drexler Pharmaceuticals has 5 board changes on record in total.
The registered office of Drexler Pharmaceuticals is at Flat No. 246 Pocket – 4 Sector – 24 Rohini, Delhi, India – 110085.
Drexler Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Drexler Pharmaceuticals is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.